economybharat.com

We Can Cover You
Click here
Facebook Twitter Youtube
13
13

FDA

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis OG_NewsReleaseCompanyLogo_92873.jpg

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

creativebharatgroup@gmail.com December 14, 2024
Zug, Switzerland:   Ad hoc announcement pursuant to Art. 53 LR   ...
Read More Read more about Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting OG_NewsReleaseCompanyLogo_92662.jpg

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

creativebharatgroup@gmail.com November 27, 2024
Vienna, Austria:   AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria,...
Read More Read more about U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting